SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$75.50 (+0.27%) as of
Key statistics
- Market cap
- 3.37B
- P/E (TTM)
- 10.16
- EPS (TTM)
- 7.43
- Dividend yield
- 5.31%
- 52-week range
- 70.00 – 80.00
- Beta
- -0.10
- Revenue (TTM)
- 1.27B
- Profit margin
- 26.07%
- Volume
- 73.33k
About SYN-TECH Chem. & Pharm. Co., Ltd.
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, a-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tainan City, Taiwan
- Employees
- 223
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.